Jeevan Scientific Technology announced Financial Results Q1 2024-25

The comprehensive analytics outlining the performance and outlook of Jeevan Scientific Technology Limited‘s stock. This analysis encompasses various metrics including stock performance, investor sentiment, market trends, future outlook, risk factors, investment opportunities, long-term strategy, dividend policy, analyst insights, and the overall risk-reward profile. These insights aim to provide investors with a holistic understanding of the company”s stock, enabling informed decision-making and strategic investment planning.

Today, we’re looking at Jeevan Scientific Technology Limited’s financial performance for the Q1(Jun 2024).Starting with the top line, the company reported a robust year-over-year sales growth of 23.98 %. However, it did see a marginal increase of 16.36 % from the previous quarter. Expenses decreased slightly by -4.26 % quarter-on-quarter, aligning with the annual rise of 15.55 %. Operating profit, while up 58.62 % compared to last year, faced a quarter-on-quarter increase of 228.57 %, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 5.46 %, but an expansion of 16.15 % sequentially. Other income fell by -50.64 % compared to the last quarter, despite an annual decline of -61.41 %. Interest expenses surged remarkably by 0 % from the previous quarter, yet the year-over-year increase remains at a moderate 43.48 %. Depreciation costs fell by -7.93 % quarter-on-quarter, whereas on an annual scale, they saw an increase of 2.72 %. Profit before tax grew annually by 138.1 % but saw an increase from the preceding quarter by 297.37 %.
Tax expenses as a percentage of profits increased slightly by 12.06 % compared to last year, with a more notable quarter-on-quarter increase of 34.89 %. Net profit rose by 101.96 % year-on-year but experienced a 241.1 % expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 106.25 % but a quarterly rise of 240.43 %. In summary, Jeevan Scientific Technology Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.

In reviewing Jeevan Scientific Technology Limited’s 2024(Q1) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales saw a robust 23.98 % year-on-year growth, however, there was a minor increase of 16.36 % from the previous quarter. Expenses rose by 15.55 % compared to the previous year, with a decrease of -4.26 % quarter-on-quarter. Operating Profit surged by 58.62 % annually, and saw a 228.57 % increase from the last quarter.
Net Profit showed yearly increase of 101.96 %, and experienced a 241.1 % increase from the previous quarter. Earnings Per Share (EPS) rose by 106.25 % annually, however rose by 240.43 % compared to the last quarter. In essence, while Jeevan Scientific Technology Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.